Print

NovaBay Pharmaceuticals, Inc. to Present at Lazard Capital Markets 9th Annual Healthcare Conference  
10/31/2012 6:43:20 AM

EMERYVILLE, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that Dr. Ron Najafi, Chief Executive Officer, will present at the Lazard Capital Markets 9th Annual Healthcare Conference, held November 13-14, 2012, in New York, NY.
//-->